Clinical Trials Directory

Trials / Completed

CompletedNCT04150133

Effects and Tolerability With Clenpiq and Low Residue Diet

The Effects and Tolerability of a Prescribed Low Residue Diet the Day Before Colonoscopy on the Cleanliness of the Colon vs. the Traditional Clear Liquid, Day Before Diet With the Use of the Clenpiq Bowel Purgative

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
154 (actual)
Sponsor
Hillmont GI · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The Efficacy of Clenpiq utilized per FDA labeling, with a low residue diet the day before colonoscopy.

Detailed description

This study proposes to assess the use of a low residue diet of a prescribed nature the day before colonoscopy for breakfast, lunch and early dinner. Clinical outcomes utilizing the low residue diet will be compared to the Food and Drug Administration (FDA) approved split dose labeling, including the traditional clear liquid diet the day before colonoscopy utilizing the Clenpiq (Ferring Pharmaceuticals) bowel preparation.

Conditions

Interventions

TypeNameDescription
OTHERLow Residue DietVariable cohort will eat 3 low residue meals on the day prior to their planned colonoscopy

Timeline

Start date
2019-11-21
Primary completion
2021-01-01
Completion
2021-10-01
First posted
2019-11-04
Last updated
2022-03-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04150133. Inclusion in this directory is not an endorsement.